Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
URINARY CATHETERISATION MANAGEMENT POLICY Guideline Reference: 1705 Type: Guideline applies to (Staff Group) Version: 3.0 Status: Adopted Clinical Policy All West Suffolk Hospital Employed SCH staff As part of transition to the new service contract this Suffolk Community Healthcare (Serco) procedural document has been adopted by West Suffolk NHS Foundation Trust with the following amendments: • Removal of Serco Equality and Diversity Impact Statement • The above is the only change to this clinical policy therefore we have not altered the version control. Where the procedural documents refer to Suffolk Community Healthcare (SCH) this is referring to those staff employed by West Suffolk NHS Foundation Trust as part of the Suffolk Community Healthcare Consortia, with The Ipswich Hospital NHS Trust and Norfolk Community Health and Care Trust. Following a 30 day settling in period, a programme of review for all SCH procedural documents aligned with West Suffolk NHS Foundation Trust will be reviewed in consultation with subject matter experts and Suffolk Community Healthcare staff. Date Adopted: 30 September 2015 Review Date: No later than 30 August 2016 S/Internal/CatheterisationUrinaryPolicy/June15/V3.0 Urinary Catheterisation Management Policy Guideline Reference: SCH Serco CP40 Version: 3.0 Status: Approved Type: Clinical Guideline applies to : All Adult services within SCH Guideline applies to (Staff Groups): All appropriate clinical staff within adult services Required compliance: This policy must be complied with fully at all times by the appropriate staff. Where it is found that this policy cannot be complied with fully, this must be notified immediately to the owner through the waiver process Guideline owner: Guideline author: Other contact: Director of Nursing Therapies and Governance Clinical Effectiveness Manager Head of Nursing and Professional Practice Date this version adopted Last review date Reviewer Next review date Location of electronic master September 2015 June 2015 CIS Consultant Nurse/ CE Manager September 2018 SCH Intranet AGREED POLICY/GUIDELINE REVIEW / RATIFICATION / ADOPTION PATH: Level 1: Agreed by: Consultant Nurse SCH Date: July 2015 Level 2: Agreed by: Clinical Policy, Audit Steering & Documentation Group Date: August 2015 (virtual) Level 4: Noted by: SLT Level 3: Agreed by: Clinical Quality & Safety Assurance Group Date: August 2015 (virtual) Date: September 2015 Name and Title of people who carried out the Name of Director who signed EQIA: EQIA: Pamela Chappell Sarah Miller, Clinical Effectiveness Manager Date EQIA completed: Signature of Director: 30/6/15 Date EQIA signed: 2/9/15 S/Internal/CatheterisationUrinaryPolicy/June15/V3.0 Contents 1. Introduction 4 2. Definitions 4 3. Indications For Urinary Catheterisation 4 4. Assessing The Need For Urinary Catheterisation 5 5. Complications Resulting From Urinary Catheterisation 5 6. Choosing A Catheter 6 7. Drainage System 7 8. Catheter Insertion 8 9. Antibiotic Prophylaxis 8 10. Suprapubic Catheterisation 10 11. Contra Indications for Catheterisation by Nursing Staff 10 12. Hygiene 10 13. Risk of Infection Following Catheter Insertion 11 14. Information And After Care 11 15. Long-Term Catheterisation 11 16. Urinary Ph 12 17. Catheter Maintenance Solutions 12 18. Catheter Specimen of Urine 12 19. Trial without Catheter 12 20. Catheter Care Audit 12 21. References 12 Appendix 1: Urethral Catheterisation Procedure 14 Appendix 2: Supra Pubic Catheterisation Procedure 18 Appendix 3: Catheter Diary 20 Appendix 4: Trouble Shooting 21 Appendix 5: Out of Hours Flowchart 22 S/Internal/CatheterisationUrinaryPolicy/June15/V3.0 URINARY CATHETERISATION MANAGEMENT POLICY 1. Introduction 1.1. Policy Objectives: a) Every member of Suffolk Community Healthcare staff dealing with urinary catheters will be able to appropriately manage them to minimise the risk of infection. b) The use and management of equipment used in urinary catheterisation will be regularly reviewed by Tissue Integrity and Appliance Group (TIAG) 1.2. Standard Statement: All staff dealing with urinary catheters must do so in a manner which minimises the risk of infection and prevents cross infection. 1.3. Training Requirements: All staff dealing with urinary catheters should ensure that they attend relevant training and assessed for competence. (See http://nww.suffolkch.nhs.uk/Home/QualityGovernance/PracticeDevel.aspx) 2. Definitions 2.1. Urethral catheter is a hollow tube inserted into the urinary bladder for the purpose of draining urine or instilling fluids as part of medical treatment. It is always done using an aseptic technique ensuring that the patient’s privacy and dignity are maintained throughout the procedure. 2.2. Supra-pubic catheter is a hollow tube inserted into an artificial tract in the abdominal wall, just above the pubic bone and into the dome of the urinary bladder for the purpose of draining urine or instilling fluids as part of medical treatment. It is often chosen for increased patient comfort and reduced infection risk. It is best practice that a urethral catheter is not used for catheterisation via this route but it is recognised that this may sometimes be unavoidable. 3. Indications For Urinary Catheterisation 3.1. Catheters should only be used: 3.2. • If the patient is in acute urinary retention • Pre / post operatively to drain the bladder contents • Decompression of chronic urinary retention • Where serious illness needs very accurate fluid balance to be recorded • To irrigate the bladder • To administer intra-vesical chemotherapy or medication • Intractable incontinence where all other types of management have failed or are inappropriate. • Intractable skin breakdown exacerbation by incontinence • The terminally ill or very frail where repeated bedding and clothing change would be distressing • Patient preference must be considered Supra-pubic catheters are commonly used for the following reasons: • Urethral trauma; existing or preventative S/Internal/CatheterisationUrinaryPolicy/July15/V3.0 4 • Congenital defects • Long-term catheterisation is required but patient is still sexually active • Post gynaecological procedure • Spinal cord patients who are unable or unwilling to use intermittent catheterisation and cannot otherwise void • Patients with detrusor sphincter dysynergia • Clinicians should be aware of the disadvantages of supra-pubic catheters which include cellulitis, leakage and prolapse through the urethra 4. Assessing The Need For Urinary Catheterisation 4.1. An indwelling catheter should only be inserted following consideration of other management alternatives. 4.2. The patient’s need for a urinary catheter should be regularly reviewed and the catheter should be removed when it is no longer needed. 4.3. Once the decision has been taken to catheterise the patient, and their informed consent obtained, then the following points need to be considered: 5. • Type of catheter • Drainage system • Catheter insertion • Antibiotic cover • Hygiene • Information and after care for the patient/ carer Complications Resulting From Urinary Catheterisation • Infective complications Asymptomatic Bacteruria Cystitis Urethritis Prostatitis Epididymitis & epididymo-orchitis Vesicoureteric reflux Pyelonephritis Abdominal wall infections Bacteraemia, septicaemia and septic shock • Urethral trauma possibly resulting in bleeding, infection and possible septicaemia • Traumatic removal of the catheter with the balloon inflated • Urinary tract infection S/Internal/CatheterisationUrinaryPolicy/July15/V3.0 5 • Bypassing of urine around the catheter • Stricture formation • Encrustation and bladder calculi • Urethral perforation • Pain, bladder spasms and / or bleeding • Catheter blockage • Creation of false passages/ fistulae 6. Choosing A Catheter 6.1. Types of catheter material: a) For routine catheterisation: Always check for known latex allergy and if this is positive then a 100% silicone catheter should be used. • Short term catheters (up to 2 weeks) – latex or PVC • Medium term (up to 28 days) – PTFE/ silicone coated • Long term (up to 3 months) -100% silicone or hydrogel coated • For supra-pubic catheterisation, always check the catheter is licensed for this use. b) For specific situations: • Open ended catheters may be useful in cases of persistent blockage • Silver alloy coated catheters are available and are licensed for 28 day use (Bardex IC) and 3 month use (Dover silver catheter - although the silver is only active for 28 days). These may be considered for patients who develop recurrent urinary infections. • Antibiotic impregnated catheters (Release NF which is impregnated with nitrofurantoin) may be considered for patients who develop recurrent urinary infections and are licensed for 3 month use. NB Epic2 guidelines state that there is no conclusive evidence currently to support the use of the silver alloy or antibiotic impregnated catheter across the board. 6.2. 6.3. Length of catheter: Consideration must include patient’s lifestyle, gender & mobility • Standard (male) 40-45cm • Female 20-26cm • Paediatric 30-31cm Recommended catheter length: • Standard length for most catheterisations 40-45cms NB NEVER use female length catheters to catheterise male patients as the inflated balloon will be within the urethra, rather than the bladder and can cause severe trauma. 6.4. Charriere and balloon size: S/Internal/CatheterisationUrinaryPolicy/July15/V3.0 6 a) The diameter of the catheter is measured in Charriere (Ch) units (1Ch=1/3mm). Select the smallest size that will allow good drainage. With urethral catheters, the smaller the external diameter of the catheter, the less irritation is caused to the urethral mucosa and the less discomfort is caused to the patient. Larger sizes may cause pain, trauma and by-passing. They may also be associated with abscess formation and an increased risk of infection. b) General recommended sizes: • Paediatric c) 6.5. 6-10 Charriere with 3-5 ml balloon • Female 12-14 Charriere with 10ml balloon • Male 14-16 Charriere with 10ml balloon The balloon should be inflated to the size stated by the manufacturer using sterile water only. Under inflation may result in the catheter falling out. There is danger of irritation of the bladder mucosa, spasm of the bladder wall and the risk of necrosis of the trigone if over inflation occurs. Select the type and gauge of an indwelling urinary catheter based on an assessment of the patient's individual characteristics, including: • Age • Any allergy or sensitivity to catheter materials • Gender • History of symptomatic urinary tract infection • Patient preference and comfort • Previous catheter history • Reason for catheterisation. 6.6. Intermittent self-catheterisation should be considered if clinically appropriate and the patient is competent and motivated to undertake this procedure. There are many catheters available for intermittent catheterisation, and should be selected to suit the patient’s ability and lifestyle. 7. Drainage System 7.1. This will depend on the reason for catheterisation and patient preference and lifestyle. 7.2. Patients should be offered a choice of either single-use hydrophilic or gel reservoir catheters for intermittent self-catheterisation. (NICE 2012) 7.3. Leg-bags are connected directly to the catheter and are supported by leg-bag straps or a support sleeve to the patient’s leg to prevent traction on the catheter. 7.4. At night, a 2 litre drainage bag is connected into the outlet from the leg-bag to allow for extra capacity. This maintains a closed system to minimise infection risk. It is recommended that the night bag should be non-drainable and therefore single use only to further reduce the risk of infection. 7.5. Night-bags should be hung on a catheter bag stand beside the bed, lower than the level of the bladder. If the night bag has a drainage tap, ensure the tap does not touch the floor. 7.6. A catheter valve may be used instead of leg-bags if a patient prefers and if clinically indicated. This must be released regularly to prevent over distension of the bladder and is generally only suitable for people who are mentally aware, have good manual dexterity, can feel the sensation of a full bladder S/Internal/CatheterisationUrinaryPolicy/July15/V3.0 7 and who have adequate bladder capacity. A night bag may be connected to the valve if the patient wishes to have continuous drainage overnight. 7.7. Leg-bags and valves should not be disconnected from the catheter except for bag change every 5-7 days, or to administer catheter maintenance solution or medication. If they are deliberately or accidentally disconnected, a new bag or valve should be connected. Writing the date of change on the bag may help with continuity of care. 7.8. Emptying the drainage bag – all staff should perform hand hygiene and put on new non-sterile gloves and disposable aprons before manipulating the catheter or drainage system, and perform hand hygiene again afterwards. A single use container should be used to empty the drainage bag contents and care should be taken not to touch the drainage tap onto the container. 8. Catheter Insertion 8.1. Catheterisation by an appropriately trained health professional: 8.2. • Must be performed using an aseptic technique. (Appendix 1) • Must be performed by personnel trained and assessed to be competent in the procedure. • Sterile, single-use lubricant should be used for both male and female catheterisation. • Meatal cleaning prior to catheterisation should follow procedure (see Appendix 1). • Documentation of the procedure must be entered into the patient’s notes and a care plan formulated, specifying the type, size, expiry date and batch number of the catheter used, the volume of sterile water used to inflate the balloon, any untoward events, the residual volume, the reason for catheterisation, and the name of the person deeming the catheterisation necessary. This should then be dated and signed. Self-catheterisation • This does not need to be an aseptic procedure. However, patients managing their own catheters, and their carers, must be educated about the need for hand decontamination before and after manipulation of the catheter (NICE 2012) 9. Antibiotic Prophylaxis 9.1. The immediate clinical and economic impact of UTI is so great that patients at risk of infections are sometimes offered the option to receive prophylactic antibiotics. 9.2. Asymptomatic bacteria (ASB) is more common in people over 65 but is not associated with increased morbidity. Diagnosis of UTI is therefore difficult so urine culture ceases to be a reliable diagnostic test. Older people often receive unnecessary antibiotic treatment for ASB despite clear evidence of adverse effects with no compensating clinical benefit (NICE 2015) 9.3. The widespread use of antibiotics, including their prophylactic use, has been identified as a major factor in the increasing levels of antibiotic resistance. There is currently an absence of evidence about the short term and long term effects of prophylactic antibiotic use during catheter changes. (NICE Quality Standards 2014) 9.4. Prudent antibiotic prescribing is a key component of the UK’s action plans for reducing antimicrobial resistance (NICE 2015) and unnecessary treatment of ASB is associated with a significantly increased risk of clinical adverse events. 9.5. Antibiotic cover is recommended by NICE guidelines 2003, 2012 in the following circumstances: S/Internal/CatheterisationUrinaryPolicy/July15/V3.0 8 9.6. a) Patients with a history of catheter associated urinary tract infections following catheter change. b) Patients who have a heart valve lesion, septal defect, patent ductus or a prosthetic valve. c) Patients who have had joint replacements or a pacemaker inserted in the last 3 months and/or are at risk of endocarditis d) There is currently no evidence base to support the routine use of antibiotic prophylaxis prior to catheterisation of MRSA positive patients. NICE Clinical Guidelines139 (NICE Evidence update 2014) made the following recommendations for preventing infection in patients with long term indwelling catheters. These are: a) Community and primary healthcare workers must be trained in catheter insertion, including suprapubic catheter replacement, and in catheter maintenance. Healthcare workers must decontaminate their hands and wear a new pair of clean, non-sterile gloves before manipulating a patient’s catheter and must decontaminate their hands after removing gloves. b) To minimise the risk of catheter-associated infections in patients with a long term indwelling catheter, health care professionals should: c) 9.7. • Develop a patient-specific care regime • Consider approaches such as reviewing the frequency of planned catheter changes and increasing fluid intake • Document catheter blockages. • Clinical need for catheterisation should be reviewed regularly and the urinary catheter removed as soon as possible. • Catheters should be changed only when clinically necessary or according to the manufacturer’s current recommendations. • Catheter insertion, changes and care should be documented. In addition NICE Quality Standard 90 (2015) advises that • Service Providers, Health Care Professional and Commissioners should ensure that all adults age 65 and over receive a full clinical assessment before a diagnosis of a urinary tract infection is made. • All men who have symptoms of an upper UTI are referred for urological examination. • Adults with a UTI who are not responding to antibiotic treatment should have a urine culture • Healthcare professionals do not prescribe antibiotics to treat ASB in adults with catheters or prophylactic antibiotics for adults with long-term catheters. Research supporting the use of oral cranberry juice in preventing urinary tract infection is limited. Some studies have demonstrated that by preventing the adherence of bacteria to the bladder mucosa, infection may be prevented. Others indicate that it may provide safe, symptomatic relief to those with urinary tract infection (Getliffe 2002). It is important to note that there is a risk of kidney stone formation if large amounts of cranberry juice are taken (University of Lancashire 1998). Cranberry juice should not be given to clients with Multiple Sclerosis (NICE 2003) or clients on oral anticoagulant therapy (CSM 2006) or Oral vitamins. S/Internal/CatheterisationUrinaryPolicy/July15/V3.0 9 10. Suprapubic Catheterisation 10.1. This involves insertion of a catheter into the bladder through the lower abdominal wall, above the symphysis pubis. A medical officer always undertakes the initial catheterisation, either under general or local anaesthetic, and also usually performs the first catheter change. Subsequent catheter changes may be undertaken by a nurse who has been trained in the technique. (Appendix 2) 10.2. The suprapubic route is especially useful after pelvic or urological surgery where the patient might have difficulty in resuming voiding. A catheter valve can be used for a trial of urethral voiding and if this is unsuccessful the valve can be released again, so avoiding repeated urethral catheterisations. Likewise, a suprapubic catheter is useful in acute retention, as voiding can be attempted without catheter removal. 10.3. Suprapubic catheterisation can be used for long term drainage and is preferential for paraplegic female patients or those with neurological deficit affecting the vulval area in order to avoid the possibility of the formation of urethra-vaginal fistula. It is also a system suitable for sexually active patients and those who experience problems with urethral catheters. 10.4. The Charriere size is often larger for this method of catheterisation in order to maintain the viability of the tract, and whilst it is best practice not to use the same types of catheters as are used for urethral catheterisation this may be unavoidable in certain circumstances. The entry site should be gently cleansed daily with mild soap and water and inspected regularly for any abnormal discharge, bleeding, inflammation or over-formation of granulation tissue. A light, dry dressing may be used to cover a newly formed suprapubic site, but once the tract is established, it may be left uncovered. Otherwise, management is the same as for a urethral catheter, the same types of bags can be used and the same information given on care. 10.5. When the suprapubic catheter is no longer required, it can simply be removed and a dry dressing applied over the site until it has healed. The opening in the bladder and abdominal walls will close spontaneously. 11. Contra Indications for Catheterisation by Nursing Staff • Less than 6 weeks post prostate surgery. • Patients with known complications/difficulty in catheterising. • No consent from the patient. • If antibiotic cover has previously been indicated but has not been administered on this occasion. Please note: • If a patient experiences pain or bleeding during the procedure, this should be ceased immediately and medical advice sought. 12. • Catheterisation should be used only after considering alternative methods of management. • The clinical need for catheterisation should be reviewed regularly and the urinary catheter removed as soon as possible. • Patients must not be catheterised to ease the workload of nursing personnel Hygiene 12.1. The patient or their carer should be taught to wash daily around the meatal/catheter junction using soap and water. This may be done when bathing or showering. S/Internal/CatheterisationUrinaryPolicy/July15/V3.0 10 12.2. Initially, supra-pubic catheter sites should be treated as a wound and will need a dressing until the tract has formed and any bleeding, exudate or discharge has stopped. A dressing is then no longer required. 12.3. Talcum powder and creams should be avoided as they can cause irritation, infection and may affect the catheter material. 13. Risk of Infection Following Catheter Insertion 13.1. Urinary catheterisation is an invasive procedure and should not be undertaken unless clinically indicated. Urinary catheters rate second only to central venous catheters as a source of hospital acquired infection. 13.2. The urinary tract is normally sterile but by introducing a catheter into the bladder the body’s natural defences are bypassed. Micro-organisms may be introduced at the time of catheterisation, and once the catheter is in situ, micro-organisms may travel intra- or extra-luminally via that catheter into the bladder. 13.3. It is estimated that approximately 12.6% of hospital patients will be catheterised during their stay in hospital, and in the community catheter care is estimated to account for approximately 4% of the Community Nurses’ caseload. The Health Protection Agency estimates that deaths from bacteraemia related to catheter associated urinary tract infections are between 13-30%. Therefore minimising the risks of catheter associated infection is an important part of nursing and medical care. 13.4. Individual needs of the patient should be considered in all aspects of catheter care. 14. Information And After Care 14.1. Wherever possible, patients and / or their carers should be independent in the ongoing management of the catheter. Information and advice should be given on catheter hygiene, hand hygiene, fluid intake, the prevention of constipation and correct use of the drainage system. 14.2. All patients should have written information via the SCH Catheter Care Leaflet http://nww.suffolkch.nhs.uk/Home/Operations/CommunityHTs/Leaflets.aspx on the continuing care of their catheter, how and where to obtain ongoing supplies and a contact number for a healthcare professional in case of emergency. 14.3. It is advisable to keep a spare catheter and equipment for re-catheterisation in the patient’s home in case of emergency. To minimise the risk of blockages, encrustations and catheter-associated infections for patients with a long-term indwelling urinary catheter: • Develop a patient-specific care regimen • Consider approaches such as reviewing the frequency of planned catheter changes and increasing fluid intake • Document catheter blockages. (NICE 2012, 2014, 2015) 14.4. For trouble shooting see Appendix 4. 15. Long-Term Catheterisation 15.1. Catheters should only be changed when clinically necessary (i.e. when blocked with debris that cannot be cleared with the appropriate catheter maintenance solution – see section 16) or according to the licensed usage time for that catheter. S/Internal/CatheterisationUrinaryPolicy/July15/V3.0 11 15.2. A catheter diary (Appendix 3) should be kept to monitor catheter changes and any problems arising. This allows for planned catheter changes to take place, pre-empting any discomfort to the patient caused by catheter blockage, and provides continuity of care. 15.3. When changing catheters in patients with a long-term indwelling urinary catheter: 16. • do not offer antibiotic prophylaxis routinely • consider antibiotic prophylaxis for patients who: have a history of symptomatic urinary tract infection after catheter change or experience trauma during catheterisation. Urinary Ph 16.1. This can range from 4.5 to 8.5. Patients with high pH will have alkaline urine, which may result in encrustation. Regular pH testing should be undertaken for patients whose catheters may be prone to blocking in order to permit planned catheter changes before they block. (Getliffe 2002) 17. Catheter Maintenance Solutions 17.1. These should only be used as part of the treatment of the catheter and must not be used routinely. 17.2. They may be used to help prolong the catheter life in patients whose catheters block excessively or when frequent catheter change is not clinically desirable. 17.3. Monitoring of urinary pH should continue in order to monitor the effectiveness of interventions. 17.4. An aseptic technique should be used in their application and a new drainage bag / valve attached afterwards. 18. Catheter Specimen of Urine 18.1. An aseptic technique MUST be used to obtain the specimen of urine from the sample port found on the drainage bag tubing and not from the catheter bag drainage tap. 19. Trial without Catheter 19.1. When staff have been requested to remove a catheter for a patient’s trial without catheter (TWOC), a subsequent contact should be made to ensure that the patient has voided satisfactorily. If possible, this should be checked by a bladder scan to check whether any residual urine remains in situ and the volume of that residual. 20. Catheter Care Audit 20.1. All staff must ensure that best practice is maintained at all times and complete the catheter care audit tool. 20.2. To ensure you are using the latest version of this tool, please ensure you access the audit toll via the SCH intranet at: http://nww.suffolkch.nhs.uk/Home/QualityGovernance/ClinicalAudit/AuditToolsRCA.aspx 21. References • ACA (2007) Notes on Good Practice for Continence Advice: www.notesongoodpractice.co.uk S/Internal/CatheterisationUrinaryPolicy/July15/V3.0 12 • DOH (2003) “Winning ways: Working together to reduce healthcare associated infection in England”, London • DOH (2007) ”Essential steps to safe, clean care” Urinary Catheter Care, London • DOH (2007) “High Impact Intervention No 6” Urinary catheter care bundle. London • Getliffe K (2002) “Managing recurrent urinary catheter encrustration”. Journal of Community Nursing 7(11):574- 80 • NICE (2014) “Evidence Update 64; NICE CG139” National Institute for Clinical Excellence, London • NICE (2003, 2012) “Care of patients with long-term urinary catheters. Guidelines on the prevention of healthcare associated infections in primary and community care (clinical guideline no 139).” National Institute for Clinical Excellence, London • NPSA (2009) – Rapid Response Report Female urinary catheters causing trauma to adult males. National Patient Safety Agency • Pratt RJ, Pellowe C. Loveday HP et al (2001) “The EPIC project: developing national evidencebased guidelines for preventing healthcare associated infections. Phase 1: guidelines for guidelines for preventing hospital acquired infections”. Journal of Hospital Infection 47, S3-82 • Pratt RJ et al (2007) “Epic 2: National evidence-based guidelines for preventing healthcare associated infections in NHS hospitals in England”. Journal of Hospital Infection 65S: S1-64 • Booth F and Clarkson M (2012): “Principles of Urinary Catheterisation” Journal of Community Nursing; 26/3; May/ June 2012 • Royal College of Nursing (2012): “Catheter Care: RCN Guidance for Nurse” • NICE (2015) “Urinary Tract Infections in Adults” Quality Standard 90 https://www.nice.org.uk/guidance/qs90 S/Internal/CatheterisationUrinaryPolicy/July15/V3.0 13 Appendix 1: Urethral Catheterisation Procedure Equipment Required Protection for bed Sterile catheter pack (or equivalent sterile supplies) Catheter 2 pairs sterile gloves 0.9% sterile saline or water Anaesthetic lubricant gel 10mls water for injection, syringe and needle Syringe to deflate balloon Drainage bag, leg straps/catheter valves Bactericidal alcohol hand rub/soap and water Disposable plastic apron Stand for drainage bag Notes Male/Female as appropriate Warmed to room temperature Sterile sealed unit Not required for pre filled balloons If removing previous catheter If required Female Catheterisation Action 1. Explain and discuss the procedure and obtain consent 2. Consider the need for antibiotic cover (do not give routinely; see section 9 above) 3. Assist the patient to get into the supine position with knees bent, hips flexed and feet resting about 60cms apart 4. Ensure that a good light source is available 5. Wash hands using bactericidal soap or bactericidal alcohol handrub 6. Put on a disposable apron 7. 8. 9. 10. Rationale To ensure that the patient understands the procedure and gives valid consent To reduce the risk of infection To enable genital area to be seen To enable the genital area to be seen clearly To reduce the risk of cross infection To reduce the risk of cross infection from microorganisms on uniform Position a disposable pad under the To protect bedding and mattress patient’s buttocks Prepare equipment using aseptic To reduce the risk of introducing infection into the technique. urinary tract Clean hands with a bactericidal alcohol Hands may have become contaminated by handrub handling outer packs etc Put on sterile gloves To reduce the risk of cross infection 11. Place sterile towel across the patient’s thighs 12. Using low-linting swabs, separate the labia minora so that the urethral meatus is seen. One hand should be used to maintain labial separation until catheterization is completed 13. Cleanse labia and urethral meatus with 0.9% sodium chloride or antiseptic solution using single downward strokes S/Internal/CatheterisationUrinaryPolicy/July15/V3.0 To create a sterile field This manoeuvre provides better access to the urethral orifice and helps to prevent labial contamination of the catheter. Inadequate preparation of the urethral orifice is a major cause of infection following catheterization. To reduce the risk of cross-infection 14 14. Apply 6ml anaesthetic gel to urethral meatus. Wait 3-5 minutes for anaesthetic effect. 15. Insert catheter gently into urethra in an upward and backward direction for 5-6cm. Stop if patient experiences pain/bleeding occurs. 16. For indwelling catheters, advance the catheter further 6-8 cm and inflate balloon according to manufacturer’s instructions. Adequate lubrication helps to prevent urethral trauma. Use of a local anaesthetic minimizes the patient's discomfort The direction of insertion and the length of catheter inserted should relate to the anatomical structure of the area. This prevents the balloon from becoming trapped in the urethra. Inadvertent inflation of the balloon within the urethra is painful and causes urethral trauma 17. Withdraw the catheter slightly then To ensure that the balloon is inflated and the connect catheter to compatible drainage catheter is secure. system or valve. 18. Secure with leg straps or sleeve. Bag To maintain patient comfort and to reduce the risk should be below bladder level to promote of urethral and bladder neck trauma. Care must be drainage taken in using adhesive tapes as they may interact with the catheter material 19. Ensure urine has drained. To ensure patency of catheter 20. Measure the amount of urine and take a To be aware of bladder capacity for patients who specimen for laboratory inspection if have presented with urinary retention. To monitor required. renal function and fluid balance. It is not necessary to measure the amount of urine if the patient is having the urinary catheter routinely changed 21. Dispose of equipment by appropriate To prevent environmental contamination method 22. Document procedure fully on completion. To provide a point of reference or comparison in Record should include: the event of later queries a. Reasons for catheterisation b. Date and time of catheterisation Check that all these prompts are in care plan on c. Catheter type, length and size LHCT documentation d. Amount of water instilled into the balloon e. Batch number and manufacturer f. Any problems negotiated during the procedure g. A review date to assess the need for continued catheterisation or date for change of catheter S/Internal/CatheterisationUrinaryPolicy/July15/V3.0 15 Male Catheterisation 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. Action Explain and discuss the procedure and obtain consent Consider the need for antibiotic cover (do not give routinely; see section 9 above) Assist the patient to get into the supine position with knees bent, hips flexed and feet resting about 60cms apart Ensure that a good light source is available Wash hands using bactericidal soap or bactericidal alcohol handrub Put on a disposable apron Rationale To ensure that the patient understands the procedure and gives valid consent To reduce the risk of infection To enable genital area to be seen To enable the genital area to be seen clearly To reduce the risk of cross infection To reduce the risk of cross infection from microorganisms on uniform Position a disposable pad under the To protect bedding and mattress patient’s buttocks Prepare equipment using aseptic To reduce the risk of introducing infection into the technique. urinary tract Clean hands with a bactericidal alcohol Hands may have become contaminated by handrub handling outer packs etc Put on sterile gloves To reduce the risk of cross infection 11. Place sterile towel across the patient’s thighs 12. Wrap a sterile topical swab around the penis. Retract the foreskin, if necessary, and clean the glans penis with 0.9% sodium chloride or sterile water. 13. Insert the nozzle of the lubricating jelly into the urethra. Squeeze 11ml of the gel into the urethra, remove the nozzle and discard the tube. Massage the gel along the urethra. 14. Hold the penis and wipe underside of shaft in downward direction with dry swab to encourage gel towards the prostatic urethra 15. Grasp the penis behind the glans, raising it until it is almost totally extended. Maintain grasp of penis until the procedure is finished 16. Place the receiver containing the catheter between the patient's legs. With penis extended at an angle of approximately 65%, insert the catheter into the urethra smoothly for 15–25 cm until urine flows. 17. If resistance is felt at the external sphincter, increase the traction on the S/Internal/CatheterisationUrinaryPolicy/July15/V3.0 To create a sterile field To reduce the risk of introducing infection to the urinary tract during catheterization. Adequate lubrication helps to prevent urethral trauma. Use of a local anaesthetic minimizes the patient's discomfort To prevent loss of gel and ensure maximum efficacy This manoeuvre straightens the penile urethra and facilitates catheterization. Maintaining a grasp of the penis prevents contamination and retraction of the penis. The direction of insertion and the length of catheter inserted should relate to the anatomical structure of the area. The male urethra is approximately 18 cm long and this ensures that the catheter is in the bladder Some resistance may be due to spasm of the external sphincter. Straining gently helps to relax 16 18. 19. 20. 21. 22. 23. penis slightly and apply steady, gentle pressure on the catheter. Ask the patient to strain gently as if passing urine Stop and withdraw catheter if patient complains of pain and/ or bleeding occurs When urine begins to flow, advance the catheter almost to its bifurcation. Gently inflate the balloon according to the manufacturer's direction, having ensured that the catheter is draining properly beforehand. Withdraw the catheter slightly and attach it to the drainage system. Support the catheter, if the patient desires, either by using a specially designed support, for example Simpla G-Strap, or by taping the catheter to the patient's leg. Ensure that the catheter does not become taut when patient is mobilizing or when the penis becomes erect. Ensure that the catheter lumen is not occluded by the fixation device or tape. Ensure that the glans penis is clean and then reduce or reposition the foreskin. 24. Make the patient comfortable. Ensure that the area is dry. 25. Measure the amount of urine and take a specimen for laboratory inspection if required. the external sphincter. To reduce the risk of trauma and prevent patient discomfort Advancing the catheter ensures that it is correctly positioned in the bladder. Inadvertent inflation of the balloon in the urethra causes pain and urethral trauma To ensure that the balloon is inflated and the catheter is secure. To maintain patient comfort and to reduce the risk of urethral and bladder neck trauma. Care must be taken in using adhesive tapes as they may interact with the catheter material Retraction and constriction of the foreskin behind the glans penis (paraphimosis) may occur if this is not done If the area is left wet or moist, secondary infection and skin irritation may occur. To be aware of bladder capacity for patients who have presented with urinary retention. To monitor renal function and fluid balance. It is not necessary to measure the amount of urine if the patient is having the urinary catheter routinely changed To prevent environmental contamination 26. Dispose of equipment by appropriate method 27. Document procedure fully on completion. To provide a point of reference or comparison in Record should include: the event of later queries • Reasons for catheterisation • Date and time of catheterisation • Catheter type, length and size • Amount of water instilled into the balloon • Batch number and manufacturer • Any problems negotiated during the procedure • A review date to assess the need for continued catheterisation or date for change of catheter S/Internal/CatheterisationUrinaryPolicy/July15/V3.0 17 Appendix 2: Supra Pubic Catheterisation Procedure 4. Action Explain and discuss the procedure and obtain consent Antibiotic cover not usually required for this procedure. Wash hands using bactericidal soap or bactericidal alcohol handrub Put on a disposable apron 5. Put on sterile gloves 6. Place a sterile towel around the insertion site Prior to procedure, clamp drainage bag Position a disposable pad under the patient’s buttocks Prepare equipment using aseptic technique. Measure new catheter against existing one Clean around existing catheter using saline and lint free gauze. Apply anaesthetic/ lubricating gel to the supra-pubic site if required 1. 2. 3. 7. 8. 9. 10. 11. 12. 13. Deflate balloon of existing catheter. 14. Gently press down with fingers on the skin surface, rotate the catheter and in an upward motion pull the catheter out; this may require a little force if required. Insert new catheter of the same size within 10 minutes for the first change and 30 mins thereafter. Advance into the tract a little further than one removed Once urine starts to flow, proceed another 2cms Stop procedure if patient complains of pain or bleeding or there is prolonged resistance Inflate balloon according to manufacturer’s instructions. 15. 16. 17. 18. S/Internal/CatheterisationUrinaryPolicy/July15/V3.0 Rationale To ensure that the patient understands the procedure and gives valid consent The risk of infection is lower for this procedure providing asepsis is maintained To reduce the risk of cross infection To reduce the risk of cross infection from microorganisms on uniform To reduce the risk of cross infection To create a sterile field To ensure bladder partially filled with urine. To protect bedding and mattress To reduce the risk of introducing infection into the urinary tract To provide guide of length needed to insert new catheter To reduce the risk of cross infection To allow smooth and pain-free passage of the catheter and reduce trauma and stricture formation To allow removal of existing catheter To facilitate easy and rapid removal To prevent closure of the insertion site To ensure that the catheter is correctly positioned in the bladder To ensure patient comfort and reduce the risk of trauma To ensure retention of the catheter within the bladder 18 19. 20. 21. 22. Connect catheter to compatible drainage system or valve and secure drainage bag to patient’s leg using an appropriate retaining strap Measure the amount of urine and take a specimen for laboratory inspection if required. To reduce trauma to bladder neck and promote good drainage To be aware of bladder capacity for patients who have presented with urinary retention. To monitor renal function and fluid balance. It is not necessary to measure the amount of urine if the patient is having the urinary catheter routinely changed Dispose of equipment by appropriate To prevent environmental contamination method Document procedure fully on To provide a point of reference or comparison in completion. Record should include: the event of later queries • Reasons for catheterisation • Date and time of catheterisation • Catheter type, length and size • Amount of water instilled into the balloon • Batch number and manufacturer • Any problems negotiated during the procedure • A review date to assess the need for continued catheterisation or date for change of catheter S/Internal/CatheterisationUrinaryPolicy/July15/V3.0 19 Appendix 3: Catheter Diary CATHETER DIARY CONTINENCE ADVISORY SERVICE Patient’s Name: Date of Initial Catheterisation: Address: Reason for Initial Catheterisation/ Name of person agreeing rationale GP Practice Address: Type of Catheter: Date Urethral or Supra Pubic Catheter Type Rationale for Change Comments Size Routine Bypassing Blocked Weeks since last change ……….. Routine Bypassing Blocked Weeks since last change ……….. Routine Bypassing Blocked Weeks since last change ……….. PH of urine Debris Crystallisation Inside of catheter checked? Results Other PH of urine Debris Crystallisation Inside of catheter checked? Results Other PH of urine Debris Crystallisation Inside of catheter checked? Results Other mls water Lot Number Expiry Date Size mls water Lot Number Expiry Date Size mls water Lot Number Expiry Date S/Internal/CatheterisationUrinaryPolicy/July15/V3.0 Signature 20 Appendix 4: Trouble Shooting Problem No drainage Bypassing Infection (symptomatic) Bleeding Pain/ discomfort Unable to deflate balloon No urinary return following insertion of suprapubic catheter Possible Cause Anuria Evidence Consensus good practice Tubing kinked Straighten tubing. Drainage bag below Robinson J. 2004 bladder. Faecal impaction Rectal examination and appropriate Stewart 2001 treatment. Dietary advice. Encrustation/ blockage Test pH or urine. If high (alkaline) Rew 2005 consider ways of reducing this. Replace catheter. Instillations should be used NICE 2006 with caution (see installation guidelines). Catheter too large Try smaller gauge. Robinson J. 2004 Tubing kinked Straighten. Robinson J. 2004 Bladder Irritation Increase fluid intake. Antibiotics only if Robinson J. 2004 indicated. Detrusor overactivity (bladder Try smaller gauge catheter. Robinson J. 2004 spasm) Anticholinergic therapy. Constipation Assess and advise as required. Robinson J. 2004 Poor catheter care CSU for microbiology. NICE 2006 Contamination Teach correct catheter care and NICE 2006 promote personal hygiene. Ensure adequate/increased fluid intake Robinson J. 2004 including cranberry juice (see section 9.5 above) Infection See above. Robinson J. 2004 Trauma Check history and catheter position. Robinson J. 2004 Heavy/ persistent bleeding Seek medical advice. Robinson J. 2004 Cramps Should settle after 24hours. Unstable bladder Consider anticholinergic drugs. Robinson J. 2004 Urethral discomfort Smaller catheter. Robinson J. 2004 Check for constipation Manage as appropriate. Robinson J. 2004 Check non return valve on Aspirate using needle and syringe. inflation channel. If 10ml balloon try using a 20ml syringe DO NOT CUT CATHETER OR SEEK ADVICE FROM UROLOGIST. Bristol Urological INFLATION CHANNEL Institute Guidelines 2005 Catheter encrusted Consider Suby G instillation. Empty bladder If no urinary drainage occurs 5-10 Robinson J. 2004 minutes after insertion, 10-15mls sterile 0.9% sodium chloride may be instilled gently into bladder and returned to confirm correct position of catheter if urine stained S/Internal/CatheterisationUrinaryPolicy/July15/V3.0 Action Medical advice. Appendix 5: Out of Hours Flowchart S/Internal/CatheterisationUrinaryPolicy/July15/V3.0 Any identified a potential discriminatory impact must be identified with a mitigating action plan to address avoidance/reduction of this impact. This tool must be completed and attached to any SCH approved document when submitted to the appropriate committee for consideration and approval. Name of Policy: Urinary Catheterisation Policy Equality Impact Assessment Tool 1. Yes/No Does the policy affect one group less or more favourably than another on the basis of: No Race No Ethnic origins (including gypsies and travellers) No Nationality No Gender No Culture No Religion or belief No Sexual orientation including lesbian, gay and bisexual people No Age No Disability - learning disabilities, physical disability, sensory impairment and mental health problems No 2. Is there any evidence that some groups are affected differently? No 3. If you have identified potential discrimination, are any exceptions valid, legal and/or justifiable? N/A 4. Is the impact of the policy/guidance likely to be negative? No 5. If so can the impact be avoided? N/A 6. What alternatives are there to achieving the policy/guidance without the impact? N/A 7. Can we reduce the impact by taking different action? N/A S/Internal/CatheterisationUrinaryPolicy/July15/V3.0 Comments